FDA Approves Rebif Rebidose Interferon Beta-1a For Multiple Sclerosis
Thursday, January 3, 2013 - 11:10
in Health & Medicine
Merck Serono, a division of Germany's Merck, announced that the U.S. Food and Drug Administration (FDA) approved Rebif(R) Rebidose(R) (interferon beta-1a), a single-use auto-injector for the self-administration of Rebif, a disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS). read more